Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Protein Particles (0.1 υm to 100 υm)

Published

Author(s)

Dean C. Ripple, Linda Narhi

Abstract

Protein molecules in solution can form proteinaceous particles by a variety of aggregation processes. The size and concentration of these particles is an important quality attribute for therapeutic MAb solutions. In this chapter, we describe the techniques commonly used to determine size and count of particles in solution for the size range 1 µm to 100 µm. After first discussing general principles of particle formation and properties, we present general guidance on sample handling and particle measurement, and then give detailed guidance on the application of the two most common techniques: light obscuration and flow imaging. The chapter concludes with a description of advanced techniques suitable for measurement of these particles.
Citation
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study
Publisher Info
ACS Publications, Washington, DC

Keywords

aggregation, flow microcopy, flow imaging, light obscuration, mab, monoclonal antibody, particle, protein

Citation

Ripple, D. and Narhi, L. (2015), Protein Particles (0.1 υm to 100 υm), ACS Publications, Washington, DC, [online], https://doi.org/10.1021/bk-2015-1201.ch008 (Accessed May 24, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created October 15, 2015, Updated November 10, 2018